Commission Implementing Regulation (EU) 2026/180 of 19 January 2026 amending Implementing Regulations (EU) 2021/1426, (EU) 2024/221, (EU) 2023/1333, (EU) 2024/1058, (EU) 2023/1342, (EU) 2024/778, (EU) 2024/2177, (EU) 2019/805, (EU) 2020/163, (EU) 2021/1431 and (EU) 2025/161 as regards the name of the holder of the authorisation for feed additives

Type Implementing Regulation
Publication 2026-01-19
State In force
Department European Commission, SANTE
Source EUR-Lex
Reform history JSON API

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition (1), and in particular Article 13(3) thereof,

Whereas:

(1) Serine protease, endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase, endo-1,3(4)-beta-glucanase, endo-1,4-beta-xylanase, 6-phytase, protease and muramidase were authorised as feed additives (‘feed additives concerned’) for different animal species by Commission Implementing Regulations (EU) 2021/1426 (2), (EU) 2024/221 (3), (EU) 2023/1333 (4), (EU) 2024/1058 (5), (EU) 2023/1342 (6), (EU) 2024/778 (7), (EU) 2024/2177 (8), (EU) 2019/805 (9), (EU) 2020/163 (10), (EU) 2021/1431 (11) and (EU) 2025/161 (12).

(2) The holder of the authorisations for the feed additives concerned, DSM Nutritional Products Ltd., has submitted an application in accordance with Article 13(3) of Regulation (EC) No 1831/2003 proposing to change the name of the holder of the authorisations for the feed additives concerned to Novozymes A/S.

(3) The proposed change of the terms of the authorisations is purely administrative in nature and does not entail a new assessment of the feed additives concerned. The European Food Safety Authority was informed of the application.

(4) To allow Novozymes A/S to exploit its marketing rights, it is necessary to change the terms of the authorisations concerned.

(5) Implementing Regulations (EU) 2021/1426, (EU) 2024/221, (EU) 2023/1333, (EU) 2024/1058, (EU) 2023/1342, (EU) 2024/778, (EU) 2024/2177, (EU) 2019/805, (EU) 2020/163, (EU) 2021/1431 and (EU) 2025/161 should therefore be amended accordingly.

(6) Since safety reasons do not require the immediate application of the amendments made by this Regulation, it is appropriate to allow a transitional period during which existing stocks of the feed additives concerned may be used up.

(7) The measures provided for in this Implementing Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

Amendment to Implementing Regulation (EU) 2021/1426

Implementing Regulation (EU) 2021/1426 is amended as follows:

(1) in the title, the name ‘DSM Nutritional Products Ltd., represented in the Union by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’;

(2) in the second column of the Annex, the name ‘DSM Nutritional Products Ltd., represented in the Union by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’.

Article 2

Amendment to Implementing Regulation (EU) 2024/221

Implementing Regulation (EU) 2024/221 is amended as follows:

(1) in the title, the name ‘DSM Nutritional Products’ is replaced by ‘Novozymes A/S’;

(2) in the second column of the Annex, the name ‘DSM Nutritional Products’ is replaced by ‘Novozymes A/S’.

Article 3

Amendment to Implementing Regulation (EU) 2023/1333

Implementing Regulation (EU) 2023/1333 is amended as follows:

(1) in the title, the name ‘DSM Nutritional Products Ltd, represented by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’;

(2) in the second column of the Annex, the name ‘DSM Nutritional Products Ltd., represented by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’.

Article 4

Amendment to Implementing Regulation (EU) 2024/1058

Implementing Regulation (EU) 2024/1058 is amended as follows:

(1) in the title, the name ‘DSM Nutritional Products Ltd, represented by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’;

(2) in the second column of the Annex, the name ‘DSM Nutritional Products Ltd, represented by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’.

Article 5

Amendment to Implementing Regulation (EU) 2023/1342

Implementing Regulation (EU) 2023/1342 is amended as follows:

(1) in the title, the name ‘DSM Nutritional Products Ltd, represented by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’;

(2) in the second column of the Annex, the name ‘DSM Nutritional Products Ltd., represented by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’.

Article 6

Amendment to Implementing Regulation (EU) 2024/778

Implementing Regulation (EU) 2024/778 is amended as follows:

(1) in the title, the name ‘DSM Nutritional Products Ltd’ is replaced by ‘Novozymes A/S’;

(2) in the second column of the Annex, the name ‘DSM Nutritional Products Ltd’ is replaced by ‘Novozymes A/S’.

Article 7

Amendment to Implementing Regulation (EU) 2024/2177

Implementing Regulation (EU) 2024/2177 is amended as follows:

(1) in the title, the name ‘DSM Nutritional Products Ltd, represented by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’;

(2) in the second column of the Annex, the name ‘DSM Nutritional Products Ltd, represented by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’.

Article 8

Amendment to Implementing Regulation (EU) 2019/805

Implementing Regulation (EU) 2019/805 is amended as follows:

(1) in the title, the name ‘DSM Nutritional Products Ltd, represented in EU by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’;

(2) in the second column of the Annex, the name ‘DSM Nutritional Products Ltd represented in EU by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’.

Article 9

Amendment to Implementing Regulation (EU) 2020/163

Implementing Regulation (EU) 2020/163 is amended as follows:

(1) in the title, the name ‘DSM Nutritional Products Ltd. represented in the Union by DSM Nutritional Products Sp. z o.o’ is replaced by ‘Novozymes A/S’;

(2) in the second column of the Annex, the name ‘DSM Nutritional Products Ltd. represented in the Union by DSM Nutritional Products Sp. z o.o’ is replaced by ‘Novozymes A/S’.

Article 10

Amendment to Implementing Regulation (EU) 2021/1431

Implementing Regulation (EU) 2021/1431 is amended as follows:

(1) in the title, the name ‘DSM Nutritional Products Ltd, represented in the Union by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’;

(2) in the second column of the Annex, the name ‘DSM Nutritional Products Ltd. represented in the Union by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’.

Article 11

Amendment to Implementing Regulation (EU) 2025/161

Implementing Regulation (EU) 2025/161 is amended as follows:

(1) in the title, the name ‘DSM Nutritional Products Ltd, represented by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’;

(2) in the second column of the Annex, the name ‘DSM Nutritional Products Ltd., represented by DSM Nutritional Products Sp. z o.o.’ is replaced by ‘Novozymes A/S’.

Article 12

Transitional measure

The feed additives concerned, produced and labelled before the date of entry into force of this Regulation in accordance with the rules applicable before that date, may continue to be placed on the market and used until stocks are exhausted.

Article 13

Entry into force

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 19 January 2026.

For the Commission The President Ursula VON DER LEYEN

(1) OJ L 268, 18.10.2003, p. 29, ELI: http://data.europa.eu/eli/reg/2003/1831/oj.

(2) Commission Implementing Regulation (EU) 2021/1426 of 31 August 2021 concerning the authorisation of serine protease produced by Bacillus licheniformis DSM 19670 as a feed additive for chickens for fattening (holder of the authorisation: DSM Nutritional Products Ltd., represented in the Union by DSM Nutritional Products Sp. z o.o.) (OJ L 307, 1.9.2021, p. 17, ELI: http://data.europa.eu/eli/reg_impl/2021/1426/oj).

(3) Commission Implementing Regulation (EU) 2024/221 of 12 January 2024 concerning the renewal of the authorisation of a preparation of endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase and endo-1,4-beta-glucanase, produced by Trichoderma reesei ATCC 74444, as a feed additive for all poultry species for fattening, all poultry species for laying and weaned piglets (holder of authorisation: DSM Nutritional Products) and amending Implementing Regulation (EU) No 403/2013 (OJ L, 2024/221, 15.1.2024, ELI http://data.europa.eu/eli/reg_impl/2024/221/oj).

(4) Commission Implementing Regulation (EU) 2023/1333 of 29 June 2023 concerning the authorisation of a preparation of endo-1,3(4)-beta-glucanase produced by Aspergillus fijiensis CBS 589.94 as a feed additive for chickens for fattening and weaned piglets (holder of authorisation: DSM Nutritional Products Ltd, represented by DSM Nutritional Products Sp. z o.o.), amending Regulation (EC) No 1811/2005 and repealing Regulation (EC) No 1259/2004 (OJ L 166, 30.6.2023, p. 106, ELI: http://data.europa.eu/eli/reg_impl/2023/1333/oj).

(5) Commission Implementing Regulation (EU) 2024/1058 of 10 April 2024 concerning the renewal of the authorisation of a preparation of endo–1,4-beta-xylanase produced by Aspergillus oryzae DSM 33700 as a feed additive for poultry for fattening, weaned piglets, pigs for fattening, lactating sows and laying hens, the change of the terms of the authorisation and authorisation of new uses of that preparation as a feed additive for all poultry species and all Suidae (holder of authorisation: DSM Nutritional Products Ltd, represented by DSM Nutritional Products Sp. z o.o.) and repealing Implementing Regulations (EU) No 1206/2012, (EU) No 2020/995 and (EU) 2020/1034 (OJ L, 2024/1058, 11.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1058/oj).

(6) Commission Implementing Regulation (EU) 2023/1342 of 30 June 2023 concerning the renewal of the authorisation of a preparation of 6-phytase produced by Aspergillus oryzae DSM 33699 as a feed additive for poultry, pigs for fattening, weaned piglets and sows (holder of authorisation: DSM Nutritional Products Ltd, represented by DSM Nutritional Products Sp. z o.o.) and repealing Implementing Regulation (EU) No 837/2012 (OJ L 168, 3.7.2023, p. 17, ELI: http://data.europa.eu/eli/reg_impl/2023/1342/oj).

(7) Commission Implementing Regulation (EU) 2024/778 of 5 March 2024 concerning the authorisation of a preparation of protease produced by Bacillus licheniformis DSM 33099 as a feed additive for all poultry species for fattening, reared for laying and reared for breeding (holder of authorisation: DSM Nutritional Products Ltd) (OJ L, 2024/778, 6.3.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/778/oj).

(8) Commission Implementing Regulation (EU) 2024/2177 of 2 September 2024 concerning the authorisation of a preparation of 6-phytase produced with Aspergillus oryzae DSM 33737 as a feed additive for all poultry species for fattening or reared for laying or reared for breeding, sows of all Suidae species and all fin fish (holder of authorisation: DSM Nutritional Products Ltd, represented by DSM Nutritional Products Sp. z o.o.) (OJ L, 2024/2177, 3.9.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2177/oj).

(9) Commission Implementing Regulation (EU) 2019/805 of 17 May 2019 concerning the authorisation of a preparation of muramidase produced by Trichoderma reesei DSM 32338 as a feed additive for chickens for fattening and minor poultry species for fattening (holder of authorisation DSM Nutritional Products Ltd, represented in EU by DSM Nutritional Products Sp. Z o.o) (OJ L 132, 20.5.2019, p. 33, ELI: http://data.europa.eu/eli/reg_impl/2019/805/oj).

(10) Commission Implementing Regulation (EU) 2020/163 of 5 February 2020 concerning the authorisation of a preparation of muramidase produced by Trichoderma reesei DSM 32338 as a feed additive for turkeys for fattening, turkeys reared for breeding, chickens reared for breeding and other poultry species reared for breeding (holder of authorisation DSM Nutritional Products Ltd. represented in the Union by DSM Nutritional Products Sp. Z o.o) (OJ L 34, 6.2.2020, p. 34, ELI: http://data.europa.eu/eli/reg_impl/2020/163/oj).

(11) Commission Implementing Regulation (EU) 2021/1431 of 1 September 2021 concerning the authorisation of muramidase produced by Trichoderma reesei DSM 32338 as a feed additive for weaned piglets (holder of the authorisation DSM Nutritional Products Ltd, represented in the Union by DSM Nutritional Products Sp. z o.o.) (OJ L 309, 2.9.2021, p. 5, ELI: http://data.europa.eu/eli/reg_impl/2021/1431/oj).

(12) Commission Implementing Regulation (EU) 2025/161 of 29 January 2025 concerning the authorisation of a preparation of muramidase produced with Trichoderma reesei DSM 32338 as a feed additive for laying hens (holder of authorisation: DSM Nutritional Products Ltd, represented by DSM Nutritional Products Sp. z o.o.) (OJ L, 2025/161, 30.1.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/161/oj).

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.